Clinical trials: Diabetic Peripheral Neuropathy (DPN)
Diabetic Peripheral Neuropathic Pain
Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)
To evaluate the efficacy of NYX-2925 versus placebo in treating the neuropathic pain associated with diabetic peripheral neuropathy.
- Trial name
- NCT04146896
- Testing
- NYX-2925 50 mg
- Where
- 35 sites in United States
- Volunteers
- 228 people
- Sponsor
- Aptinyx
Diabetic Neuropathies
Effect of High-Dose NAC on Patients With DPN
The aim of the current study is to evaluate the efficacy and safety of high dose oral NAC (2400 mg/day divided into two doses) as an adjunct therapy on oxidative stress, inflammatory markers and clinical outcome in patients with…
- Trial name
- NAC (NCT04766450)
- Testing
- Acetyl cysteine
- Where
- Egypt
- Volunteers
- 30 people
- Sponsor
- Ain Shams University